7-5622876-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_207111.4(RNF216):c.2756C>T(p.Pro919Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000243 in 1,602,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P919P) has been classified as Likely benign.
Frequency
Consequence
NM_207111.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF216 | NM_207111.4 | c.2756C>T | p.Pro919Leu | missense_variant | 17/17 | ENST00000389902.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF216 | ENST00000389902.8 | c.2756C>T | p.Pro919Leu | missense_variant | 17/17 | 1 | NM_207111.4 | P4 | |
RNF216 | ENST00000425013.6 | c.2585C>T | p.Pro862Leu | missense_variant | 17/17 | 1 | A1 | ||
RNF216 | ENST00000389900.8 | c.*1873C>T | 3_prime_UTR_variant, NMD_transcript_variant | 16/16 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248282Hom.: 0 AF XY: 0.0000672 AC XY: 9AN XY: 133966
GnomAD4 exome AF: 0.0000262 AC: 38AN: 1450294Hom.: 0 Cov.: 31 AF XY: 0.0000334 AC XY: 24AN XY: 719040
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.2756C>T (p.P919L) alteration is located in exon 17 (coding exon 16) of the RNF216 gene. This alteration results from a C to T substitution at nucleotide position 2756, causing the proline (P) at amino acid position 919 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 22, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 919 of the RNF216 protein (p.Pro919Leu). This variant is present in population databases (rs771029566, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RNF216-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at